期刊文献+

MiR-182在结直肠癌中的表达及其对结直肠癌细胞迁移能力的影响 被引量:11

Expression of miR-182 in colorectal cancer and its effect on the migration of colorectal cancer cells
原文传递
导出
摘要 目的检测miR-182在结直肠癌中的表达情况及与临床病理参数的关系,探讨其对结直肠癌细胞迁移能力的影响。方法实时荧光定量PCR(qRT-PCR)检测86例患者结直肠癌与对应癌旁组织中miR-182的表达情况,分析其与结直肠癌临床病理参数之间的关系。体外用miR-182 mimics和阴性对照转染结直肠癌HT-29细胞,将实验分为miR-182组、阴性对照组和空白组,transwell小室实验观察miR-182对HT-29细胞迁移能力的影响。结果 MiR-182在结直肠癌的表达显著高于癌旁(P<0.001),其表达水平与患者的浸润程度(P=0.028)、淋巴结转移(P=0.003)、远处转移(P=0.006)和临床分期(P=0.005)密切相关,而与年龄、性别、肿瘤类型、肿瘤大小和分化程度无相关性(P均>0.05)。体外实验进一步表明,miR-182过表达的HT-29细胞迁移数显著高于阴性对照组和空白组(P均<0.05)。结论 MiR-182在结直肠癌中高表达且与肿瘤的转移及进展有关,体外能增强结直肠癌细胞的迁移能力,提示miR-182可作为预防和治疗结直肠癌转移的潜在靶点。 Objective To detect the expression level of miR-182 in colorectal cancer, explore the correlations between miR-182 expression and clinicopathological features, and investigate its effect on the migration of colorectal cancer ceils in vitro. Methods Quantitative real-time PCR (qRT-PCR) was used to measure the expression of miR-182 in 86 pairs of colorectal cancer and corresponding adjacent noncancerous tissues, and the correlations between miR-182 expression and clinicopathological features were further analyzed. HT-29 cells were transiently transfected with miR-182 mimics and miR-negative control, and the experiment was divided into miR-182 over-expression group, negative control group and blank group. In addition, the migration ability was detected by transwell assay in vitro. Results The expression of miR-182 was significantly higher in colorectal cancer tissues compared with corresponding adjacent noncancerous tissues ( P 〈0.001 ). Its level was significantly correlated with local invasion ( P = 0. 028 ), lymph nodes metastasis ( P = 0. 003 ), distant metastasis ( P = 0.006 ), and clinical stage ( P = 0. 005 ), respectively. However, no correlation was observed between miR-182 and age or other clinicopathological parameters (all P〉0.05). The migration cells were significantly higher in miR-182 over-expression group than negative control group and blank group. Conclusion MiR-182 is up-regulated in colorectal cancer and that high miR-182 expression is associated with the metastasis and progression of colorectal cancer. In addition, the up-regulated miR-182 promotes colorectal cancer cell migration in vitro, suggesting a potential target for the prevention and therapy of metastasis in colorectal cancer.
出处 《山东大学学报(医学版)》 CAS 北大核心 2013年第12期70-74,共5页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金重点资助项目(ZR2010H004)
关键词 结直肠癌 MiR-182 迁移 Colorectal cancer MiR-182 Migration
  • 相关文献

参考文献18

  • 1Zhao P, Dai M, Chen W, et al. Cancer trends in China[J]. Jpn J Cfin Oncol, 2010, 40(4) :281-285.
  • 2Yang L, Parkin D M, Li L, et al. Time trends in cancer mortality in China: 1987-1999 [ J]. Int J Cancer, 2003, 106(5) :771-783.
  • 3Calin G A, Croce C M. MicroRNA signatures in human cancers [ J ]. Nat Rev Cancer, 2006, 6 ( 11 ) : 857-866.
  • 4Liu Z, Liu J, Segura M F, et al. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma [J]. J Pathol, 2012, 228 (2) :204-215.
  • 5Segura M F, Hanniford D, Menendez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by re- pressing FOXO3 and microphthalmia-associated transcrip- tion factor[ J ]. Proc Nati Acad Sci U S A, 2009, 106 (6) :1814-1819.
  • 6Wang J, Li J, Shen J, et al. MicroRNA-182 downregu- lates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma[ J]. BMC Cancer, 2012, 12: 227.
  • 7Kong W Q, Bai R, Liu T, et al. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppres- ses cell growth in human gastric adenocarcinoma [ J ]. Febs J, 2012, 279(7) :1252-1260.
  • 8Sun Y, Fang R, Li C, et al. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expres- sion in vitro[ J]. Biochem Biophys Res Commun, 2010, 396(2) :501-507.
  • 9Jiang L, Mao P, Song L, et al. miR-182 as a prognostic marker for glioma progression and patient survival [ J ]. Am J Pathol, 2010, 177 ( 1 ) :29-38.
  • 10Sarver A L, French A J, Borralho P M, et al. Human colon cancer profiles show differential microRNA expres- sion depending on mismatch repair status and are charac-teristic of undifferentiated proliferative states [ J ]. BMC Cancer, 2009, 9:401.

二级参考文献17

  • 1薛剑,娄加陶.肺癌分子诊断学研究进展[J].上海交通大学学报(医学版),2011,31(3):373-377. 被引量:7
  • 2吴健虹,谢秋玲,陈小佳,洪岸.表皮生长因子受体EGFR及其信号传导[J].生命科学,2006,18(2):116-122. 被引量:40
  • 3Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identifi- cation of tissue-specific microRNAs from mouse[J]. Curr Biol, 2002, 12(9) :735-739.
  • 4Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing[J]. Cell, 2007, 129(7) :1401-1414.
  • 5Takamizawa J, Konishi H, Yanagisawa K, et al. Re- duced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative surviv- al[ J]. Cancer Res, 2004, 64(11) :3753-3756.
  • 6Yanaihara N, Caplen N, Bowman E, et al. Unique mi- croRNA molecular profiles in lung cancer diagnosis and prognosis [J]. Cancer Cell, 2006, 9 ( 3 ) : 189-198.
  • 7McManus M T. MicroRNAs and cancer [J]. Semin Cancer Biol, 2003, 13(4) :253-258.
  • 8Inui M, Martello G, Piccolo S. MicroRNA control of sig- nal transduction[ J]. Nat Rev Mol Cell Biol, 2010, 11 (4) : 252-263.
  • 9Rizzo M, Mariani L, Pitto L, et al. miR-20a and miR- 290, multi-faceted players with a role in tumourigenesis and senescence[ J]. J Cell Mol Med, 2010, 14( 11 ): 2633 -2640.
  • 10Merlo V, Longo M, Novello S, et al. EGFR pathway in advanced non-small cell lung cancer [ J ]. Front Biosci (Schol Ed), 2011, 3:501-517.

共引文献6

同被引文献96

引证文献11

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部